Joe Brice Weinberg, MD

Professor of Medicine
Associate Professor of Obstetrics and Gynecology
Professor of Immunology
Affiliate, Duke Global Health Institute
Member of the Duke Cancer Institute
Campus mail Duke Box 3396, Durham, NC 27708
Phone (919) 286-6833
Email address weinb001@duke.edu

Dr. Weinberg is a board-certified hematologist and medical oncologist who serves as Professor of Medicine and Immunology and Associate Professor of Obstetrics and Gynecology at the Duke University Medical Center, and staff physician in hematology-oncology at the Durham V.A. Medical Center. His clinical interests are in hematology and oncology, and his research focuses on blood cells, nitric oxide (NO), and leukemia. The work includes studies of resistance to infection, pathways of inflammation, and regulation of normal and leukemic cell life and death. His current work includes studies of leukemia (primarily chronic lymphocytic leukemia); the roles of NO and arginine in the resistance to malaria; and the interactions of NO, prostaglandins, and mechanical force in inflammation and arthritis.

Education and Training

  • Fellowship, Hematology Oncology, University of Utah School of Medicine, 1973 - 1976
  • Internship & Residency, University of Arkansas at Little Rock, 1969 - 1971
  • M.D., University of Arkansas at Little Rock, 1969
  • B.S., University of Arkansas, Fayetteville, 1966

Publications

Slager, Susan L., Mark C. Lanasa, Sallie D. Allgood, Sara J. Achenbach, Aaron Norman, Celine M. Vachon, Lynn Goldin, et al. “Prevalence of MBL Increases Over Time In Relatives of CLL Families.” In Blood, 118:1659–1659. AMER SOC HEMATOLOGY, 2011.

Scholars@Duke

Brander, Danielle M., Sallie D. Allgood, Karen M. Bond, J Brice Weinberg, and Mark C. Lanasa. “The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome.” In Blood, 118:1229–1229. AMER SOC HEMATOLOGY, 2011.

Scholars@Duke

Coombs, Catherine C., Laura Z. Rassenti, Susan L. Slager, Sara Strom, J Brice Weinberg, Thomas J. Kipps, and Mark C. Lanasa. “Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia.” In Blood, 118:778–79. AMER SOC HEMATOLOGY, 2011.

Scholars@Duke

Christensen, Dale J., Youwei Chen, Jessica Oddo, Karen M. Matta, Jessica Neil, Evan D. Davis, Alicia D. Volkheimer, et al. “SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target..” Blood 118, no. 15 (October 13, 2011): 4150–58. https://doi.org/10.1182/blood-2011-04-351072.

PMID
21844565
Full Text

Weinberg, J. B., Y. Chen, N. Jiang, B. E. Beasley, J. C. Salerno, and D. K. Ghosh. “Erratum: Inhibition of nitric oxide synthase by cobalamins and cobinamides (Free Radical Biology & Medicine (2009) 46 (1626-1632)).” Free Radical Biology and Medicine 51, no. 7 (October 1, 2011). https://doi.org/10.1016/j.freeradbiomed.2011.07.010.

Full Text

Lanasa, M. C., S. D. Allgood, S. L. Slager, S. S. Dave, C. Love, G. E. Marti, N. E. Kay, et al. “Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL..” Leukemia 25, no. 9 (September 2011): 1459–66. https://doi.org/10.1038/leu.2011.117.

PMID
21617698
Full Text

Slager, Susan L., Kari G. Rabe, Sara J. Achenbach, Celine M. Vachon, Lynn R. Goldin, Sara S. Strom, Mark C. Lanasa, et al. “Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL..” Blood 117, no. 6 (February 10, 2011): 1911–16. https://doi.org/10.1182/blood-2010-09-308205.

PMID
21131588
Full Text

Riera, Katherine M., Nicole E. Rothfusz, Rebecca E. Wilusz, J. B. Weinberg, Farshid Guilak, and Amy L. McNulty. “Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration..” Arthritis Res Ther 13, no. 6 (2011). https://doi.org/10.1186/ar3515.

PMID
22087734
Full Text

Pages